Skip to content
HowShorted

bluebird bio, Inc. short interest in 2021

In 2021, bluebird bio, Inc.'s disclosed short interest ran from 9.26% of shares outstanding on 15 Jan 2021 to 8.26% on 31 Dec 2021, a change of -1.00 percentage points. The year's high was 10.22% on 31 Mar 2021 and its low 7.55% on 29 Oct 2021, averaging 8.69% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.24 days on 30 Jul 2021. Full history: bluebird bio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for bluebird bio, Inc. in 2021

2021 in figures

Start of year
9.26% (15 Jan 2021)
End of year
8.26% (31 Dec 2021)
Change
-1.00 pp
High
10.22% (31 Mar 2021)
Low
7.55% (29 Oct 2021)
Average
8.69%
Highest days to cover
8.24 (30 Jul 2021)
SEC filings marked
9

Every report in 2021

bluebird bio, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20219.26%5.48results (8-K)
29 Jan 20218.96%4.80
12 Feb 20219.17%7.45
26 Feb 20219.55%1.0910-K filed, results (8-K)
15 Mar 20218.15%2.48
31 Mar 202110.22%3.44
15 Apr 202110.00%5.69
30 Apr 20219.41%6.24
14 May 20218.74%6.3410-Q filed, results (8-K)
28 May 20217.57%6.19
15 Jun 20217.93%3.38
30 Jun 20219.39%2.84
15 Jul 20218.70%6.63
30 Jul 20219.27%8.24
13 Aug 20219.35%2.8410-Q filed, results (8-K)
31 Aug 20218.45%5.09
15 Sep 20217.73%5.44
30 Sep 20218.54%5.36
15 Oct 20218.52%5.90
29 Oct 20217.55%6.16
15 Nov 20217.70%1.8810-Q filed, results (8-K)
30 Nov 20218.18%2.93
15 Dec 20217.92%2.97
31 Dec 20218.26%1.71

See also: bluebird bio, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.